PEG-MGF
Pegylated Mechano Growth Factor
PEG-MGF is a pegylated variant of Mechano Growth Factor, an engineered form of IGF-1 designed for enhanced stability and prolonged action. The pegylation process extends the half-life from minutes to days, making it highly effective for muscle fiber hyperplasia, satellite cell activation, and accelerated muscle tissue repair. Unlike standard IGF-1, PEG-MGF specifically targets muscle-specific growth pathways with reduced systemic effects.
Clinical Benefits
Mechanism of Action
PEG-MGF functions as a localized muscle growth factor that activates satellite cells through IGF-1 receptor binding. The pegylation process extends the compound's half-life from 5-7 minutes (native MGF) to 24-72 hours, allowing sustained anabolic signaling. It specifically promotes muscle fiber hyperplasia (formation of new muscle fibers) rather than just hypertrophy, leading to more permanent muscle gains. The compound activates the PI3K/Akt/mTOR pathway, enhancing protein synthesis while reducing protein breakdown.
Proven Results
Medical Disclaimer
PEG-MGF is a research chemical not approved by the FDA for human use. This information is for educational purposes only and should not replace consultation with healthcare providers. Individual results may vary significantly. Research use only - not intended for human consumption or therapeutic application.